dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Suspension
- RxCUI
- 1605844
- RxNorm name
- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Suspension
- Display name
- Dextromethorphan/guaiFENesin (Oral Liquid)
- Full name
- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Suspension
- Term type
- SCD
- Status
- Active
- Strength
- 10-100 mg/5ml
- Dose form
- Susp
- Route
- Oral Liquid
- Updated
- 2026-10-15 15:45:37
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042015
- Active start
- 042015
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| dextromethorphan hydrobromide | 2 MG / 1 ML | dextromethorphan | dextromethorphan hydrobromide |
| guaifenesin | 20 MG / 1 ML | guaifenesin | guaifenesin |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Suspension | 316969 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| dextromethorphan | 3289 |
| guaifenesin | 5032 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | dextromethorphan hydrobromide 2 MG/ML / guaiFENesin 20 MG/ML Oral Suspension | 1 | NAMES |
| RxNorm Name | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Suspension | 1 | NAMES |
| RxNorm Synonym | dextromethorphan HBr 20 MG / guaifenesin 200 MG per 10 ML Oral Suspension | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1605844 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 49580-0385-2 | 49580-0385 | Tussin DM Cough and Chest Congestion Dextromethorphan HBr, Guaifenesin | P & L Development, LLC | M012 |
| 49580-0385-4 | 49580-0385 | Tussin DM Cough and Chest Congestion Dextromethorphan HBr, Guaifenesin | P & L Development, LLC | M012 |
| 49580-0385-8 | 49580-0385 | Tussin DM Cough and Chest Congestion Dextromethorphan HBr, Guaifenesin | P & L Development, LLC | M012 |
| 63941-385-04 | 63941-385 | Tussin Cough and Chest Congestion DM Dextromethorphan HBr, Guaifenesin | Best Choice (Valu Merchandisers Company) | M012 |
| 63941-385-08 | 63941-385 | Tussin Cough and Chest Congestion DM Dextromethorphan HBr, Guaifenesin | Best Choice (Valu Merchandisers Company) | M012 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| M012 | 49580-0385 | Tussin DM Cough and Chest Congestion Dextromethorphan HBr, Guaifenesin | OTC MONOGRAPH DRUG | P & L Development, LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tussin DM Cough and Chest Congestion Adult | DEXTROMETHORPHAN HBR, GUAIFENESIN | P & L Development, LLC | 4af67ba7-8892-442c-b9fb-80aba9140e05 | 2025-10-28 | Warnings | 49580-0385-4 49580-0385-8 49580-0385-2 49580-0385 49580038502 49580038504 49580038508 1605844 |
| Tussin Cough and Chest Congestion DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Best Choice (Valu Merchandisers Company) | 0f2d371d-f890-41e5-ac11-db5559d32466 | 2024-02-02 | Warnings | 63941-385-08 63941-385-04 63941-385 63941038504 63941038508 1605844 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4af67ba7-8892-442c-b9fb-80aba9140e05 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Suspension [PSN] · dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Suspension [SCD] · dextromethorphan HBr 20 MG / guaifenesin 200 MG per 10 ML Oral Suspension [SY] | 3 | 14 | Drug Facts | 20251028 |
| 0f2d371d-f890-41e5-ac11-db5559d32466 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Suspension [PSN] · dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Suspension [SCD] · dextromethorphan HBr 20 MG / guaifenesin 200 MG per 10 ML Oral Suspension [SY] | 3 | 7 | Drug Facts | 20240202 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 4af67ba7-8892-442c-b9fb-80aba9140e05 | Drug Facts | P & L Development, LLC | 20251028 |
| 4af67ba7-8892-442c-b9fb-80aba9140e05 | Drug Facts | P & L Development, LLC | 20250530 |
| 382efbca-0a45-4ece-b43d-6948dc7c4b4d | Drug Facts | AAFES/Your Military Exchanges | 20250508 |
| 0f2d371d-f890-41e5-ac11-db5559d32466 | Drug Facts | Best Choice (Valu Merchandisers Company) | 20240202 |
| 691f5813-10bb-461c-b565-d6564dc9820d | Drug Facts | Family Dollar (FAMILY WELLNESS) | 20230130 |
| 51c2fcdb-ab31-4777-95e2-790d2b38fedf | Drug Facts | Care One (American Sales Company) | 20191030 |
| 1d539e9b-c30e-44f4-a579-7ee10976ee12 | Drug Facts | Select Brand Dist. | 20191018 |
| b464a54b-b4e1-4310-bd75-49f73c3a58a9 | Drug Facts | Select Brand Dist. | 20190415 |
| 4ba63581-bfa3-4879-8268-3ae9c85818ca | Drug Facts | Western Family Foods, Inc. | 20181228 |
| 9f3a5835-6e6f-4e6b-8419-ba3ecb109439 | BJWC TUSSIN Drug Facts | BJWC | 20160804 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | R05CA | Expectorants | ATC1-4 | guaifenesin | |
| ATC | R05DA | Opium alkaloids and derivatives | ATC1-4 | dextromethorphan | |
| FDASPL | N0000193956 | Expectorant | EPC | has_epc | guaifenesin |
| FDASPL | N0000182149 | Sigma-1 Agonist | EPC | has_epc | dextromethorphan |
| FDASPL | N0000181821 | Uncompetitive N-methyl-D-aspartate Receptor Antagonist | EPC | has_epc | dextromethorphan |
| FDASPL | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan |
| FDASPL | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan |
| MEDRT | D003915 | Dextromethorphan | CHEM | has_ingredient | dextromethorphan hydrobromide |
| MEDRT | D003915 | Dextromethorphan | CHEM | has_ingredient | dextromethorphan |
| MEDRT | D006140 | Guaifenesin | CHEM | has_ingredient | guaifenesin |
| MEDRT | D001991 | Bronchitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_prevent | dextromethorphan |
| MEDRT | D003371 | Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dextromethorphan hydrobromide |
| MEDRT | D003371 | Cough | DISEASE | may_prevent | dextromethorphan hydrobromide |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dextromethorphan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dextromethorphan hydrobromide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dextromethorphan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | guaifenesin |
| MEDRT | D007827 | Laryngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D010612 | Pharyngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | guaifenesin |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D014917 | Whooping Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | dextromethorphan |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | dextromethorphan hydrobromide |
| MEDRT | N0000000109 | Serotonin Uptake Inhibitors | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000000109 | Serotonin Uptake Inhibitors | MOA | has_moa | dextromethorphan |
| MEDRT | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan |
| MEDRT | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan |
| MEDRT | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | dextromethorphan |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | dextromethorphan hydrobromide |
| MEDRT | N0000008867 | Decreased Respiratory Secretion Viscosity | PE | has_pe | guaifenesin |
| MEDRT | N0000009560 | Increased Respiratory Secretions | PE | has_pe | guaifenesin |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 2 MG/ML / 20 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | VUID | 4005468 |
| NAMES | Prescribable Synonym | dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Suspension |
| NAMES | Tallman Synonym | dextromethorphan HBr 20 MG / guaiFENesin 200 MG per 10 ML Oral Suspension |
| NAMES | Tallman Synonym | dextromethorphan hydrobromide 2 MG/ML / guaiFENesin 20 MG/ML Oral Suspension |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Veterans Health Administration National Drug File |